Transce3nd’s Halozyme HALO Stock Holding History

Transce3nd’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21	Closed	-$1.09K	–	574
2025 Q2	$1.09K	Hold	21	–	–	﹤0.01%	968
2025 Q1	$1.34K	Hold	21	–	–	﹤0.01%	915
2024 Q4	$1K	Buy	+21	New	+$1.08K	﹤0.01%	1212

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Transce3nd's HALO Position: Q3 2025 in Review

Transce3nd sold out of Halozyme (HALO) in Q3 2025, closing a stake of 21 shares — an estimated $1.09K sold.

Transce3nd first reported a position in HALO in Q4 2024 and held it in 3 quarters. The position peaked at $1.34K in Q1 2025. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

Transce3nd reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 21 Halozyme shares in Q3 2025, an estimated $1.09K.
Transce3nd first reported a position in Halozyme in Q4 2024 and held it in 3 quarters.
Transce3nd's Halozyme position peaked at $1.34K in Q1 2025.
602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.